Literature DB >> 2392651

Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills.

S Valdemarsson1, L Edvinsson, P Hedner, R Ekman.   

Abstract

Calcitonin gene-related peptide (CGRP) is one of the peptides encoded for by the calcitonin gene. It has been demonstrated in man to be located in the thyroid and in perivascular nerves and to possess potent vasodilatory properties. In the present study we found plasma levels of calcitonin gene-related peptide-like immunoreactivity (CGRP-LI) to be significantly higher in females than in males and that women on contraceptive pills had significantly higher CGRP-LI levels than women not taking contraceptives. These data are in accordance with one earlier report on an increased CGRP level during pregnancy and suggest a positive influence of the female sex hormones on the plasma CGRP level in man, which should be considered in the establishment of a reference range for this analysis.

Entities:  

Keywords:  Age Factors; Biology; Comparative Studies; Contraception; Contraceptive Methods; Demographic Factors; Examinations And Diagnoses; Family Planning; Hemic System--analysis; Hemic System--men; Hemic System--women; Laboratory Examinations And Diagnoses; Oral Contraceptives; Physiology; Population; Population Characteristics; Research Methodology; Studies

Mesh:

Substances:

Year:  1990        PMID: 2392651     DOI: 10.3109/00365519009091595

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  10 in total

Review 1.  Sex Differences in Chronic Migraine: Focusing on Clinical Features, Pathophysiology, and Treatments.

Authors:  Chia-Kuang Tsai; Chia-Lin Tsai; Guan-Yu Lin; Fu-Chi Yang; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2022-02-26

Review 2.  Role of Estrogens in Menstrual Migraine.

Authors:  Rossella E Nappi; Lara Tiranini; Simona Sacco; Eleonora De Matteis; Roberto De Icco; Cristina Tassorelli
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

Review 3.  Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?

Authors:  Maria Alice Oliveira; William Gustavo Lima; Dante Alighieri Schettini; Cristiane Queixa Tilelli; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2018-10-10       Impact factor: 3.633

4.  Differential Synovial CGRP/RAMP1 Expression in Men and Women With Knee Osteoarthritis.

Authors:  Kentaro Uchida; Shotaro Takano; Ken Takata; Manabu Mukai; Tomohisa Koyama; Yoshihisa Ohashi; Hiroki Saito; Masashi Takaso; Masayuki Miyagi; Gen Inoue
Journal:  Cureus       Date:  2021-06-06

Review 5.  Gender aspects of CGRP in migraine.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Cephalalgia       Date:  2017-10-30       Impact factor: 6.292

6.  Effects of Calcitonin-Gene-Related-Peptide on Auditory Nerve Activity.

Authors:  Colleen G Le Prell; Larry F Hughes; David F Dolan; Sanford C Bledsoe
Journal:  Front Cell Dev Biol       Date:  2021-11-12

7.  Serum CGRP in migraine patients using erenumab as preventive treatment.

Authors:  Gisela M Terwindt; Antoinette MaassenVanDenBrink; Simone de Vries Lentsch; Ingrid M Garrelds; A H Jan Danser
Journal:  J Headache Pain       Date:  2022-09-12       Impact factor: 8.588

8.  Plasma calcitonin gene-related peptide (CGRP) in migraine and endometriosis during the menstrual cycle.

Authors:  Bianca Raffaelli; Lucas Hendrik Overeem; Jasper Mecklenburg; Maxi Dana Hofacker; Henriette Knoth; Claus Peter Nowak; Lars Neeb; Andreas Dietmar Ebert; Jalid Sehouli; Sylvia Mechsner; Uwe Reuter
Journal:  Ann Clin Transl Neurol       Date:  2021-05-02       Impact factor: 4.511

Review 9.  Sex-Specific Pharmacotherapy for Migraine: A Narrative Review.

Authors:  Parisa Gazerani; Brian E Cairns
Journal:  Front Neurosci       Date:  2020-03-20       Impact factor: 4.677

Review 10.  Gender-related differences in migraine.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2020-12       Impact factor: 3.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.